VerifyMe Inc
For the period ended Mar 31, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 13, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements (Unaudited)
NOTE 1 –SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of the Business
VerifyMe, Inc. (“VerifyMe,” “we,” “us,” “our,” or the “Company”) was incorporated in the State of Nevada on November 10, 1999. VerifyMe, is based in Lake Mary, Florida and its common stock, par value $0.001 per share, and certain warrants to purchase common stock are traded on The Nasdaq Capital Market (“Nasdaq”) under the trading symbols “VRME” and “VRMEW,” respectively.
The Company is a logistics company that specializes in time and temperature sensitive products, as well as providing brand protection and enhancement solutions. The Company operates a Precision Logistics segment which includes the operations of our subsidiary PeriShip Global, LLC (“PeriShip Global”) and accounts for nearly all VerifyMe revenue and an Authentication segment. Through our Precision Logistics segment, we provide a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, sort volumes, and traffic, delivered to customers via a secure portal. The portal provides real-time visibility into shipment transit and last-mile events which is supported by a service center. Through our Authentication segment our technologies enable brand owners to deter counterfeit activities. Further information regarding our business segments is discussed below. The Company’s activities are subject to significant risks and uncertainties. See the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in this report.
Reclassifications
Certain amounts presented for the three months ended March 31, 2024, reflect reclassifications made to conform to the presentation in our current reporting period. These reclassifications had no effect on the previously reported net loss.
Basis of Presentation
The accompanying unaudited interim consolidated financial statements include the accounts of VerifyMe and its wholly owned subsidiary PeriShip Global. All significant intercompany balances and transactions have been eliminated upon consolidation. The consolidated financial statements have been prepared pursuant to the rules and regulations for reporting on Form 10-Q. Accordingly, certain information and disclosures required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements are not included herein. The Interim Statements should be read in conjunction with the financial statements and notes thereto included in the Company’s latest Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission (the “SEC”) on March 12, 2025. The accompanying Interim Statements are unaudited; however, in the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The interim results for the three months ended March 31, 2025, are not necessarily indicative of the results to be expected for the year ending December 31, 2025, or for any future interim periods.
Segment Reporting
Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker, or decision-making group, in deciding the method by which to allocate resources and assess performance. The Company has two reportable segments, namely, (i) Precision Logistics and (ii) Authentication. See Note 11 Segment Reporting, for further discussion of the Company’s segment reporting structure.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
***Recent Accounting Pronouncements ***
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The guidance requires disclosure of disaggregated income taxes paid, prescribes standardized categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. ASU 2023-09 is effective for the Company’s annual periods beginning January 1, 2025, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on their financial statement disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Topic 220). This standard requires disclosure of specific information about costs and expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating the potential effect that the updated standard will have on their financial statement disclosures.
Fair Value of Financial Instruments
The Company’s financial instruments consist of accounts receivable, unbilled revenue, accounts payable, notes payable and accrued expenses, equity investments, and long-term derivatives. The carrying value of accounts receivable, unbilled revenue, accounts payable and accrued expenses approximate their fair value because of their short maturities. The Company believes the carrying amount of its notes payable approximates fair value based on rates and other terms currently available to the Company for similar debt instruments.
The Company follows FASB Accounting Standard Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures, and applies it to all assets and liabilities that are being measured and reported on a fair value basis. The statement requires that assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data
Level 3: Unobservable inputs that are not corroborated by market data
The level in the fair value within which a fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.
The following table presents the Company’s financial instruments that are measured and recorded at fair value on the Company’s balance sheets on a recurring basis, and their level within the fair value hierarchy as of March 31, 2025 and December 31, 2024.
Amounts in Thousands ('000)
| Schedule of fair value assets measured on recurring basis | ||
|---|---|---|
| Derivative Asset | ||
| (Level 2) | ||
| Balance as of December 31, 2024 | 12 | |
| Termination of SWAP, recognized in other comprehensive loss | (12) | |
| Balance at March 31, 2025 | $ | - |
Revenue Recognition
The Company accounts for revenues according to ASC Topic 606,Revenue from Contracts with Customers which establishes principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash flows arising from the entity's contracts to provide goods or services to customers.
The Company applies the following five steps, separated by reportable segments, in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements.
| · | identify the contract with a customer; |
| · | identify the performance obligations in the contract; |
| · | determine the transaction price; |
| · | allocate the transaction price to performance obligations in the contract; and |
| · | recognize revenue as the performance obligation is satisfied. |
The Company generally considers completion of an agreement, or Statement of Work (“SOW”) and/or purchase order as a customer contract, provided collection is considered probable. For more detailed information about reportable segments, see Note 11 – Segment reporting.
Precision Logistics
Our Precision Logistics segment consists of two service lines, Proactive and Premium. Under our Proactive service line, clients pay us directly for carrier service coupled with our proactive logistics service. Terms typically range 7 days and no longer than 30 days. The Company has determined it is the principal and recognizes shipment fees in gross revenue. Under our Premium service line, we provide complete white-glove shipping monitoring and predictive analytics services. This service includes customer web portal access, weather monitoring, temperature control, full-service center support and last mile resolution. Payment terms are typically 30 - 45 days.
Under both service lines in our Precision Logistics segment, our performance obligation is met, and revenue is recognized when the packages are delivered. The transaction fees consist of fixed consideration made up of amounts contractually billed to the customer. There are no variable considerations in the transaction fee, in either service line.
Authentication
Our Authentication segment primarily consists of anti-counterfeit and brand protection. Terms typically range between 30 and 60 days. Our performance obligation is met, and revenue is recognized when our products are shipped or delivered depending on the specific agreement with the customer. The transaction fee is made up of fixed consideration based on the related purchase order or agreement.
Goodwill
Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations. Pursuant to ASC Topic 350, Intangibles-Goodwill and Other, the Company tests goodwill for impairment on an annual basis in the fourth quarter, or between annual tests, in certain circumstances. Under authoritative guidance, the Company first assessed qualitative factors to determine whether it was necessary to perform the quantitative goodwill impairment test. The assessment considers factors such as, but not limited to, macroeconomic conditions, data showing other companies in the industry and our share price. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. Events or changes in circumstances which could trigger an impairment review include macroeconomic conditions, industry and market conditions, cost factors, overall financial performance, other entity specific events and sustained decrease in share price.
Basic and Diluted Net Loss per Share of Common Stock
The Company follows ASC Topic 260, Earnings Per Share, when reporting earnings per share resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss for each of the periods presented, common stock equivalents, including preferred stock, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and diluted loss per share were the same.
For the three months ended March 31, 2025, and 2024, there were shares potentially issuable, that could dilute basic earnings per share in the future that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive to the Company’s losses during the periods presented. For the three months ended March 31, 2025, there were approximately 7,534,000 anti-dilutive shares consisting of 1,504,000 unvested performance restricted stock units,454,000 restricted stock units and restricted stock awards,151,000 shares issuable upon exercise of stock options,4,629,000 shares issuable upon exercise of warrants,652,000 shares issuable upon conversion of convertible debt, and 144,000 shares issuable upon conversion of preferred stock. For the three months ended March 31, 2024, there were approximately 8,383,000 anti-dilutive shares consisting of 1,559,000 unvested performance restricted stock units, 785,000 restricted stock units, restricted stock awards and options under the stock purchase plan,301,000 shares issuable upon exercise of stock options,4,629,000 shares issuable upon exercise of warrants,957,000 shares issuable upon conversion of convertible debt,8,000 shares issuable in connection with earnout earned for the Trust Codes Acquisition, and 144,000 shares issuable upon conversion of preferred stock.
Stock-Based Compensation
We account for stock-based compensation under the provisions of ASC Topic 718, Compensation—Stock Compensation, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. We estimate the fair value of stock-based awards on the date of grant using the Black-Scholes model. The assumptions used in the Black-Scholes option pricing model include risk-free interest rates, expected volatility and expected life of the stock options. Changes in these assumptions can materially affect estimates of fair value stock-based compensation, and the compensation expense recorded in future periods. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line method. We recognize forfeitures as they occur with a reduction in compensation expense in the period of forfeiture. For performance restricted stock units (“RSU”) with stock price appreciation targets (see Note 6 – Stock Options, Restricted Stock and Warrants), we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the RSU’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the performance period and there is no ongoing adjustment or reversal based on actual achievement during the period.
We account for stock-based compensation awards to non-employees in accordance with ASU No. 2018-07, Compensation – Stock Based Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity – Equity-Based Payments to Non-Employees.
All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Non-employee equity-based payments are recorded as an expense over the service period, as if we had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity-based payments will be re-measured, and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity-based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity-based payments are fully vested or the service completed.** **
NOTE 2 –REVENUE
Revenue by Category
The following series of tables present our revenue disaggregated by various categories (dollars in thousands).
| Schedule of disaggregation of revenue | ||||||||
|---|---|---|---|---|---|---|---|---|
| Precision Logistics · Authentication · Consolidated | ||||||||
| Revenue · Three Months Ended March 31, · Three Months Ended March 31, · Three Months Ended March 31, | ||||||||
| 2025 · 2024 · 2025 · 2024 · 2025 · 2024 | ||||||||
| Proactive services | $3,694 | $4,225 | $ | - | $ | - | $3,694 | $4,225 |
| Premium services | 735 | 1,389 | - | - | 735 | 1,389 | ||
| Brand protection services | - | - | 26 | 145 | 26 | 145 | ||
| $4,429 | $5,614 | $26 | $145 | $4,455 | $5,759 | |||
Contract Balances
The timing of revenue recognition, billings and cash collections results in unbilled revenue (contract assets) and deferred revenue (contract liabilities) on the consolidated balance sheets. Amounts charged to our clients become billable according to the contract terms, which usually consider the delivery completion. Unbilled amounts will generally be billed and collected within 30 days but typically no longer than 60 days. When we advance bill clients prior to the work being performed, generally, such amounts will be earned and recognized in revenue within twelve months. These assets and liabilities are reported on the consolidated balance sheets on a contract-by-contract basis at the end of each reporting period. Changes in the contract asset and liability balances during the three-month period ended March 31, 2025, were not materially impacted by any other factors.
Applying the practical expedient in ASC Topic 606, we recognize the incremental costs of obtaining contracts (i.e. sales commissions) as an expense when incurred if the amortization period of the assets that we otherwise would have recognized is one year or less. As of March 31, 2025, we did not have any capitalized sales commissions.
For all periods presented, contract liabilities were not significant.
The following table provides information about contract assets from contracts with customers:
| Schedule of contract assets from contracts with customers | ||
|---|---|---|
| Contract Asset | ||
| March 31, | ||
| In Thousands | 2025 | 2024 |
| Beginning balance, January 1 | $733 | $1,282 |
| Contract asset additions | 641 | 916 |
| Reclassification to accounts receivable, billed to customers | (733) | (1,282) |
| Ending balance, March 31 (1) | $641 | $916 |
| (1) | Included within "Unbilled revenue" on the accompanying Consolidated Balance sheets. |
NOTE 3 –BUSINESS COMBINATIONS
On December 8, 2024, the Company sold Trust Codes Global pursuant to a Share Sale Agreement with a related party, Paul Ryan, former Executive Vice President of the Authentication Segment and employee of Trust Codes Global Limited. This divestiture did not qualify as a discontinued operation. The purchase price per the agreement was $1 NZD. We recognized a loss of $0.1 million on the sale of the business. Through his purchase, Mr. Ryan assumed the remaining cash balance in the bank accounts of $0.1 million and all continuing obligations and liabilities of Trust Codes Global Limited. The Trust Codes Global business was part of the Authentication segment.
NOTE 4 –INTANGIBLE ASSETS AND GOODWILL
Goodwill
Goodwill represents costs in excess of values assigned to the underlying net assets of acquired businesses. Intangible assets acquired are recorded at estimated fair value. Goodwill is deemed to have an indefinite life and is not amortized but is tested for impairment annually, and at any time when events suggest an impairment more likely than not has occurred. We test goodwill at the reporting unit level.
ASC Topic 350, “Intangibles - Goodwill and Other”(“ASC Topic 350”), permits an entity to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative goodwill impairment test. Under ASC Topic 350, an entity is not required to perform a quantitative goodwill impairment test for a reporting unit if it is more likely than not that its fair value is greater than its carrying amount. A reporting unit is an operating segment, or one level below an operating segment, as defined by U.S. GAAP.
Determining the fair value of a reporting unit is judgmental in nature and involves the use of significant estimates and assumptions. These estimates and assumptions include revenue growth rates and operating margins used to calculate projected future cash flows, risk-adjusted discount rates, future economic and market conditions and determination of appropriate market comparables. We base our fair value estimates on assumptions we believe to be reasonable but are unpredictable and inherently uncertain. Actual future results may differ from those estimates. The timing and frequency of our goodwill impairment tests are based on an ongoing assessment of events and circumstances that would indicate a possible impairment. We will continue to monitor our goodwill and intangible assets for impairment and conduct formal tests when impairment indicators are present.
Each of our two reportable segments represents an operating segment under ASC Topic 280,Segment Reporting. We test our goodwill at the reporting unit level, or one level below an operating segment, under ASC Topic 350, “Intangibles - Goodwill and Other”. We determined that we have two reporting units for purposes of goodwill impairment testing, which represent our two reportable business segments, as discussed below.
Changes in the carrying amount of goodwill by reportable business segment for the three months ended March 31, 2025, were as follows (in thousands):
| Schedule of goodwill by reportable business segment | ||||
|---|---|---|---|---|
| Authentication · Precision Logistics · Total | ||||
| Net book value at | ||||
| January 1, 2025 | $ | - | $3,988 | $3,988 |
| 2025 Activity | ||||
| Net book value at | ||||
| March 31, 2025 | $ | - | $3,988 | $3,988 |
Intangible Assets Subject to Amortization
Our intangible assets include amounts recognized in connection with patents and trademarks, capitalized software and acquisitions, including customer relationships, tradenames, developed technology and non-compete agreements. Intangible assets are initially valued at fair market value using generally accepted valuation methods appropriate for the type of intangible asset. Amortization is recognized on a straight-line basis over the estimated useful life of the intangible assets. Intangible assets with definite lives are reviewed for impairment if indicators of impairment arise. Except for goodwill, we do not have any intangible assets with indefinite useful lives.
Intangible assets with finite lives are subject to amortization over their estimated useful lives. The primary assets included in this category and their respective balances were as follows (in thousands):
| Schedule of intangible assets subject to amortization | ||||
|---|---|---|---|---|
| March 31, 2025 | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Weighted Average Remaining Useful Life (Years) |
| Patents and Trademarks | $1,112 | $(252) | $860 | 10 |
| Customer Relationships | 1,839 | (541) | 1,298 | 7 |
| Developed Technology | 3,143 | (1,541) | 1,602 | 3 |
| Internally Used Software | 1,568 | (264) | 1,304 | 5 |
| Non-Compete Agreement | 191 | (112) | 79 | 2 |
| Deferred Implementation | 135 | (31) | 104 | 8 |
| Total Intangible Assets | $7,988 | $(2,741) | $5,247 | |
| Patents and Trademarks | $1,112 | $(230) | $882 | 10 |
| Customer Relationships | 1,839 | (495) | 1,344 | 7 |
| Developed Technology | 3,143 | (1,411) | 1,732 | 3 |
| Internally Used Software | 1,418 | (207) | 1,211 | 7 |
| Non-Compete Agreement | 191 | (103) | 88 | 2 |
| Deferred Implementation | 135 | (27) | 108 | 8 |
| Total Intangible Assets | $7,838 | $(2,473) | $5,365 | |
Amortization expense for intangible assets was $274 thousand and $269 thousand for the three months ended March 31, 2025, and 2024, respectively.
Patents and Trademarks
As of March 31, 2025, our current patent and trademark portfolios consist of seven granted U.S. patents and one granted European patents, two pending foreign patent applications and several foreign trademarks.
The Company expects to record amortization expense of intangible assets over the next 5 years and thereafter as follows (in thousands):
| Schedule of future amortization expense | |
|---|---|
| Fiscal Year ending December 31, | |
| 2025 (nine months remaining) | $832 |
| 2026 | 1,067 |
| 2027 | 1,040 |
| 2028 | 664 |
| 2029 | 505 |
| Thereafter | 1,139 |
| Total | $5,247 |
NOTE 5 –STOCKHOLDERS’ EQUITY
The Company expensed $55 thousand and $148 thousand related to restricted stock awards for the three months ended March 31, 2025, and 2024, respectively.
The Company expensed $237 thousand and $264 thousand related to restricted stock units for the three months ended March 31, 2025, and 2024, respectively.
On March 31, 2025, the Company issued 60,000 shares of restricted common stock, vesting immediately with a value of $41 thousand, for consulting services.
On January 2, 2025, the Company issued 39,915 shares of common stock, of which 16,988 were issued from treasury, upon vesting of 61,011 restricted stock units, net of 21,096 shares withheld for taxes related to stock grants on July 20, 2023 and July 1, 2024.
On August 25, 2023, the Company entered into a Convertible Note Purchase Agreement with certain investors for the sale of convertible promissory notes for the aggregate principal amount of $1,100 thousand. As of January 21, 2025, $350 thousand was converted to 313,520 shares of common stock, of which 22,359 were issued from treasury.
Non-Qualified Stock Purchase Plan
On June 10, 2021, the stockholders of the Company approved a non-qualified stock purchase plan (the “2021 Plan”). The 2021 Plan provides eligible participants, including employees, directors and consultants of the Company, the opportunity to purchase shares of the Company’s common stock thereby increasing their interest in the Company’s continued success. The maximum number of common stock reserved and available for issuance under the 2021 Plan is 500,000 shares. The purchase price of shares of common stock acquired pursuant to the exercise of an option will be the lesser of 85% of the fair market value of a share (a) on the enrollment date, and (b) on the exercise date. The 2021 Plan is not intended to qualify as an employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended (the “Code”). The Company applied ASC Topic 718, Compensation-Stock Compensation and estimated the fair value using the Black-Scholes model, as the 2021 Plan is considered compensatory. In relation to the 2021 Plan the Company expensed $0 thousand and $4 thousand for the three months ended March 31, 2025 and March 31, 2024, respectively. During the three months ended March 31, 2025 and 2024, the Company received $0 thousand and $21 thousand, respectively, in proceeds related to the 2021 Plan. The Company has currently suspended new offering periods under the 2021 Plan.
Shares Held in Treasury
As of March 31, 2025, and December 31, 2024, the Company had 251,120 and 290,467 shares, respectively, held in treasury with a value of approximately $351 thousand and $480 thousand, respectively.
On February 29, 2024, seven participants exercised their option under the Company’s non-qualified stock purchase plan, and as a result,21,889 shares were issued from treasury, with an exercise price of $0.97 per share.
Shares Repurchase Program
In December 2023, the Company’s Board of Directors approved a share repurchase program to allow the Company to spend up to $0.5 million to repurchase shares of its common stock so long as the price does not exceed $1.00 until December 14, 2024. On November 26, 2024, the Company approved an extension of the $0.5 million share repurchase program to repurchase shares of the Company’s common stock through December 31, 2025. The share repurchase program may be modified, suspended or discontinued at the discretion of the Board at any time. The Company did not repurchase any shares during the three months ended March 31, 2025.
NOTE 6 –STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS
On November 14, 2017, the Executive Committee of the Company’s Board of Directors adopted the 2017 Equity Incentive Plan (the “2017 Plan”) which covered the potential issuance of 260,000 shares of common stock. The 2017 Plan provided that directors, officers, employees, and consultants of the Company were eligible to receive equity incentives under the 2017 Plan at the discretion of the Board or the Board’s Compensation Committee.
On August 10, 2020, the Company’s Board of Directors adopted the 2020 Equity Incentive Plan (the “2020 Plan”) and on September 30, 2020, the Company’s stockholders approved the 2020 Plan, which authorizes the potential issuance of up to 1,069,110 shares of common stock. Upon effectiveness of the 2020 Plan the 2017 Plan was terminated. Shares of common stock underlying existing awards under the 2017 Plan may become available for issuance pursuant to the terms of the 2020 Plan under certain circumstances. Employees and non-employee directors of the Company or its affiliates, and other individuals who perform services for the Company or any of its affiliates, are eligible to receive awards under the 2020 Plan at the discretion of the Board of Directors or the Board’s Compensation Committee.
On March 28, 2022, the Company’s Board of Directors adopted the First Amendment to the 2020 Plan and on June 9, 2022, the Company’s stockholders approved the First Amendment to the 2020 Plan, which increased the shares authorized for potential issuance under the 2020 Plan to 2,069,100 shares of common stock and extended the term of the 2020 Plan to June 9, 2023. On April 17, 2023, the Company’s Board of Directors adopted the Second Amendment to the 2020 Plan and on June 6, 2023, the Company’s stockholders approved the Second Amendment to the 2020 Plan, which increased the shares authorized for potential issuance under the 2020 Plan to 3,069,110 shares of common stock and extended the term of the 2020 Plan to June 6, 2033, and increased the annual cap on director compensation by $50 thousand. On March 18, 2024, the Company’s Board of Directors adopted the Third Amendment to the 2020 Plan, which on June 4, 2024, was approved by the Company’s stockholders, which increased the shares authorized for potential issuance under the 2020 Plan to 4,069,100 shares of common stock and extended the term of the 2020 Plan to June 4, 2034.
The 2020 Plan, as amended, is administered by the Compensation Committee which determines the persons to whom awards will be granted, the number of awards to be granted and the specific terms of each grant, including the vesting thereof, subject to the provisions of the plan.
In connection with incentive stock options, the exercise price of each option may not be less than 100% of the fair market value of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10% of the outstanding stock of the Company). The aggregate fair market value (determined at the time of the grant) of stock with respect to which incentive stock options are exercisable for the first time by any individual during any calendar year (under all plans of the Company and its affiliates) shall not exceed $100 thousand, and the options in excess of $100 thousand shall be deemed to be non-qualified stock options, including prices, duration, transferability and limitations on exercise. The maximum number of shares of common stock that may be issued under the 2020 Plan pursuant to incentive stock options may not exceed, in the aggregate,1,000,000.
The Company has issued non-qualified stock options pursuant to contractual agreements with non-employees. Options granted under the agreements are expensed when the related service or product is provided. Determining the appropriate fair value of stock-based awards requires the input of subjective assumptions. The Company uses the Black-Scholes option pricing model to value its stock option awards. The assumptions used in calculating the fair value represent management’s best estimates and involve inherent uncertainties and judgements.
Stock Options
The following table summarizes the activities for the Company’s stock options as of March 31, 2025:
| Schedule of stock options | |||||
|---|---|---|---|---|---|
| Options Outstanding | |||||
| Weighted - | |||||
| Average | |||||
| Remaining · Aggregate | |||||
| Weighted- · Contractual · Intrinsic | |||||
| Number of · Average · Term · Value | |||||
| Shares · Exercise Price · (in years) · (in thousands)(1) | |||||
| Balance as of December 31, 2024 | 221,000 | $3.57 | 0.4 | $ | - |
| Granted | - | - | |||
| Forfeited/Cancelled/Expired | (70,000) | 3.51 | |||
| Balance as of March 31, 2025 | 151,000 | $3.61 | 0.3 | $ | - |
| Exercisable as of March 31, 2025 | 151,000 | $3.61 | 0.3 | $ | - |
| (1) | The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. |
As of March 31, 2025, the Company had no unvested stock options.
During the three months ended March 31, 2025, and 2024, the Company expensed $0 thousand, with respect to options.
As of March 31, 2025, there was $0 unrecognized compensation cost related to outstanding stock options.
Restricted Stock Awards and Restricted Stock Units
The following table summarizes the unvested restricted stock awards as of March 31, 2025:
| Schedule of unvested restricted stock awards | ||
|---|---|---|
| Weighted - | ||
| Average | ||
| Number of | Grant | |
| Award Shares | Date Fair Value | |
| Unvested at December 31, 2024 | 140,000 | $1.60 |
| Granted | - | - |
| Vested | - | - |
| Balance at March 31, 2025 | 140,000 | $1.60 |
As of March 31, 2025, total unrecognized share-based compensation cost related to unvested restricted stock awards is $41 thousand, which is expected to be recognized over a weighted-average period of less than one year.
The following table summarizes the unvested restricted stock units as of March 31, 2025:
| Schedule of unvested restricted stock units | ||
|---|---|---|
| Weighted - | ||
| Average | ||
| Number of | Grant | |
| Unit Shares | Date Fair Value | |
| Unvested at December 31, 2024 | 273,736 | $1.38 |
| Granted | 86,773 | 1.75 |
| Vested | (41,011) | 1.37 |
| Forfeited | (5,000) | 1.37 |
| Balance at March 31, 2025 | 314,498 | $1.48 |
As of March 31, 2025, total unrecognized share-based compensation cost related to unvested time-based restricted stock units was $185 thousand, which is expected to be recognized over a weighted-average period of less than one year.
The following table summarizes the unvested performance-based restricted stock units as of March 31, 2025:
| Schedule of unvested performance restricted stock units | ||
|---|---|---|
| Number of Unit Shares | Weighted - Average Number of Unit Shares | |
| Unvested at December 31, 2024 | 1,606,660 | $1.37 |
| Granted | - | - |
| Forfeited/Cancelled | (103,125) | 1.41 |
| Balance at March 31, 2025 | 1,503,535 | $1.37 |
For restricted stock units with stock price appreciation targets, we applied a lattice approach that incorporated a Monte Carlo simulation, which involved random iterations that took different future price paths over the restricted stock unit’s contractual life based on the appropriate probability distributions (which are based on commonly applied Black Scholes inputs). The fair value of each grant was determined by taking the average of the grant date fair values under each Monte Carlo simulation trial. We recognize compensation expense on a straight-line basis over the derived service period and there is no ongoing adjustment or reversal based on actual achievement during the period.
As of March 31, 2025, total unrecognized share-based compensation cost related to unvested performance based restricted stock units was $357 thousand, which is expected to be recognized over a weighted-average period of 1.1 years.
Warrants
The following table summarizes the activities for the Company’s warrants as of March 31, 2025:
| Schedule of warrants outstanding | |||||
|---|---|---|---|---|---|
| Number of Warrant Shares · Weighted- Average Exercise Price · Weighted - Average Remaining Contractual Term (in years) · Aggregate Intrinsic Value (in thousands)(1) | |||||
| Balance as of December 31, 2024 | 4,628,586 | 4.13 | 1.2 | ||
| Granted | 1,461,896 | 4.00 | |||
| Exercised | (1,461,896) | 3.22 | |||
| Balance as of March 31, 2025 | 4,628,586 | $4.38 | 1.9 | ||
| Exercisable as of March 31, 2025 | 4,628,586 | $4.38 | 1.9 | $ | - |
| (1) | The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.68 for our common stock on March 31, 2025. |
On January 13, 2025, the Company entered into a warrant inducement agreement with an institutional investor and holder of existing warrants to purchase up to 1,461,896 shares of our common stock. The existing warrants were originally issued on April 14, 2022, with an exercise price of $3.215 per share and became exercisable six months following issuance. The net proceeds from the warrant exercise was $4.3 million. In exchange for the investor’s exercise of the existing warrants, the Company issued new warrants to purchase an equal number of shares at an exercise price of $4.00 per share. The new warrants were immediately exercisable and have a contractual term of five and one-half years from the issuance date.
The Company recognized the fair value of the new warrants using the Black-Scholes option pricing model. The fair value of the new warrants were estimated at $3,971 thousand. The transaction was treated as an equity issuance, and the fair value of the new warrants was recorded in additional paid-in capital. Direct transaction costs totaling approximately $352 thousand, including legal fees and placement agent commissions, were also recorded as a reduction to additional paid-in capital.
The following table presents the assumptions used to estimate the fair value of the new warrants on January 13, 2025:
| Schedule of assumptions used | |
|---|---|
| Risk free interest rate | 4.34% |
| Expected life | 2.75 years |
| Expected volatility | 171% |
| Expected dividend | - |
At-the-Market Equity Offering Program
On March 6, 2025, the Company entered into an At-The-Market Sales Agreement (“ATM”) with Roth Capital Partners, LLC (“Roth”), pursuant to which the Company may issue and sell, from time to time, shares of its common stock up to an aggregate offering price of $15.8 million. Roth acts as the Company’s sales agent and is entitled to a 3.0% commission on gross proceeds from sales under the program.
In connection with the ATM program, the Company incurred direct legal and audit fees totaling $100 thousand. These costs have been recorded as deferred offering costs within other current assets and will be reclassified to additional paid-in capital on a pro-rata basis as shares are issued. Deferred offering costs will be assessed for recoverability at each reporting period. If management determines that the ATM program is not probable to be utilized, the deferred costs will be expensed to general and administrative expenses.
During the three months ended March 31, 2025, and as of the date of this filing, we have not sold any shares of common stock through the ATM.
NOTE 7—DEBT
PeriShip Global is a party to a debt facility with PNC Bank, National Association (the “PNC Facility”). The PNC Facility includes a $1 million revolving line of credit (the “RLOC”). The RLOC has no scheduled payments of principal until maturity, and bears interest per annum at a rate equal to the sum of Daily SOFR plus 2.85% with monthly interest payments. The PNC Facility also included a four-year term note (the “Term Note”) for $2 million which matured in September of 2026 and required equal quarterly payments of principal and interest. The Term Note incurred interest per annum at a rate equal to the sum of Daily SOFR plus 3.1%. On January 21, 2025, the Term Note was paid in full and no future principal payments are due. The PNC Facility is guaranteed by VerifyMe and secured by the assets of PeriShip Global and VerifyMe.
The PNC Facility includes a number of affirmative and restrictive covenants applicable to PeriShip Global, including, among others, a financial covenant to maintain a fixed charge coverage ratio of at least 1.10 to 1.00 at the end of each fiscal year, affirmative covenants regarding delivery of financial statements, payment of taxes, and establishing primary depository accounts with PNC Bank, and restrictive covenants regarding dispositions of property, acquisitions, incurrence of additional indebtedness or liens, investments and transactions with affiliates. PeriShip Global is also restricted from paying dividends or making other distributions or payments on its capital stock if an event of default (as defined in the PNC Facility) has occurred or would occur upon such declaration of dividend. On August 14, 2024, the Company signed a waiver and amendment which provided a waiver for a certain event of default and extended the line of credit to September 30, 2025. On February 28, 2025, we received a waiver as of December 31, 2024 for certain events of default. PeriShip Global was in compliance with all affirmative and restrictive covenants under the PNC Facility at March 31, 2025.
As of January 21, 2025, the Term Note balance of $875 thousand was paid in full and no future principal payments are due.
As of March 31, 2025, $0 was outstanding on the RLOC.
Effective October 17, 2022, the Company entered into an interest rate swap agreement, with a notional amount of $1,958 thousand, effectively fixing the interest rate on the Company’s outstanding debt at 7.602%. The Company had designated the intertest rate swap, expiring September 2026, as a cash flow hedge and have applied hedge accounting. The fair value of the derivative asset and liability associated with the interest rate swap are not significant. As of January 21, 2025, we terminated our interest rate swap agreement and $12 thousand was reclassified from accumulated other comprehensive loss.
Convertible Debt
On August 25, 2023, the Company entered into a Convertible Note Purchase Agreement with certain investors for the sale of convertible promissory notes for the aggregate principal amount of $1,100 thousandof which $475 thousand waspurchased by related parties including certain members of management and the Board of Directors. As of December 31, 2024, $450 thousand was held by related parties after one member of management left the Company. The notes are subordinated unsecured obligations of the Company and accrue interest at a rate of 8% per year payable semiannually in arrears on February 25 and August 25 of each year, beginning on February 25, 2024. The notes will mature on August 25, 2026, unless earlier converted or repurchased at a conversion price of $1.15 per share of common stock. The Company may not redeem the notes prior to the maturity date. For the three months ended March 31, 2025 and March 31, 2024, interest expense related to the convertible debt was $15 thousand and $22 thousand, respectively. As of January 21, 2025, $350 thousand was converted to common stock, none of which was related parties. As of March 31, 2025 and December 31, 2024, the amount outstanding on the convertible debt was $750 thousand and $1,100 thousand, respectively and included in Convertible note and Convertible note – related party on the accompanying Consolidated Balance Sheets.
NOTE 8—INCOME TAXES
There areno taxes payable as of March 31, 2025, or December 31, 2024.
Some of the federal tax carry forwards will expire at various dates through 2037. Generally, these can be carried forward and applied against future taxable income at the tax rate applicable at that time. We are currently using an effective income tax rate of 21% for our projected available net operating loss carry-forward. No tax benefit has been recognized in the three months ending March 31, 2025, due to the uncertainty surrounding the realizability of the benefit. As of March 31, 2025, the Company had no unrecognized tax benefits.
Utilization of the net operating losses (NOL) carryforwards may be subject to a substantial annual limitation as required by Section 382 of the IRC, due to ownership changes of the company that could occur in the future, as well as similar state provisions. In general, an “ownership change” as defined by Section 382 results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points of the outstanding stock of a company by certain stockholders. These ownership changes may limit the amount of NOL carryforwards that can be utilized annually to offset future taxable income.
In accordance with FASB ASC 740 “Income Taxes”, valuation allowances are provided against deferred tax assets, if based on the weight of available evidence, some or all, of the deferred tax assets may or will not be realized. The Company did not utilize any NOL deductions for the three months ended March 31, 2025.
NOTE 9–LEASES
The Company accounts for its leases under Accounting Standard Codification (“ASC”) Topic 842,“Leases”. The Company determines at its inception whether an arrangement that provides us control over the use of an asset is a lease. We recognize at lease commencement a right-of-use (ROU) asset and lease liability based on the present value of the future lease payments over the lease term. We have elected not to recognize a ROU asset and lease liability for leases with terms of 12 months or less. Our current long-term leases include an option to extend the term of the lease prior to the end of the initial term. It is not reasonably certain that we will exercise the option and have not included the impact of the option in the lease term for purposes of determining total future lease payments. As our lease agreement does not explicitly state the discount rate implicit in the lease, we use our promissory note borrowing rate to calculate the present value of future payments.
In addition to the base rent, real estate leases typically contain provisions for common-area maintenance and other similar services, which are considered non-lease components for accounting purposes. For our real estate leases, we apply a practical expedient to include these non-lease components in calculating the ROU asset and lease liability. For all other types of leases, non-lease components are excluded from our ROU assets and lease liabilities and expensed as incurred.
We have operating leases for office facilities. We do not have any finance leases.
Lease expenses are included in General & administrative expenses on the accompanying Consolidated Statements of Operations. The components of lease expense were as follows (in thousands):
| Schedule of components of lease expense | ||
|---|---|---|
| Three months ended March 31, | ||
| 2025 | 2024 | |
| Operating lease cost | $26 | $47 |
| Short-term lease cost | 4 | 5 |
| Total lease costs | $30 | $52 |
Supplemental information related to leases was as follows (dollars in thousands):
| Schedule of supplemental information related to leases | ||||
|---|---|---|---|---|
| March 31, 2025 · December 31, 2024 | ||||
| Operating Lease right-of-use asset | $100 | $236 | ||
| Current portion of operating lease liabilities | $48 | $108 | ||
| Non-current portion of operating lease liabilities | 54 | 139 | ||
| Total operating lease liabilities | $102 | $247 | ||
| Cash paid for amounts included in the measurement of operating lease liabilities | $30 | $126 | ||
| Right-of-use assets obtained in exchange for operating lease liabilities | $ | - | $ | - |
| Weighted-average remaining lease term for operating leases (years) | 2.1 | 2.3 | ||
| Weighted average discount rate for operating leases | 7.4% | 6.0% | ||
The following is a reconciliation of future undiscounted cash flows to the operating lease liabilities on our consolidated balance sheets as of March 31, 2025 (in thousands):
| Schedule of operating lease liabilities maturities | |
|---|---|
| Year ending December 31, | |
| 2025 (Excluding three months ended March 31, 2025) | $36 |
| 2026 | 55 |
| 2027 | 19 |
| Total future lease payments | 110 |
| Less: imputed interest | (8) |
| Present value of future lease payments | 102 |
| Less: current portion of lease liabilities | (48) |
| Long-term lease liabilities | $54 |
NOTE 10–CONCENTRATIONS
For the three months ended March 31, 2025 and 2024, one customer represented 15% and 22% of revenues, respectively.
During the three months ended March 31, 2025, and 2024, one vendor accounted for 99% of transportation cost in our Precision Logistics segment.
As of March 31, 2025, one customer made up 41%of accounts receivable, net. As of December 31, 2024, two customers made up 36% of accounts receivable.
NOTE 11 –SEGMENT REPORTING
As of March 31, 2025, we operated through two reportable business segments: (i) Precision Logistics and (ii) Authentication. The Chief Executive Officer is the chief operating decision maker (“CODM”). These segments reflect the way the CODM evaluates the Company’s business performance and allocates resources. The CODM assesses performance by using revenue, gross margin, operating expenses and net earnings. These metrics are analyzed by reviewing budget and forecast versus actual and prior year versus current year reporting. The various income performance measures are reviewed to ensure proper pricing strategies, effective cost controls and cash management across the organization. Reported revenue includes only the revenue generated by sales to external customers.
**Precision Logistics:**This segment offers a value-added service provider for time and temperature sensitive parcel management. Through logistics management from a sophisticated IT platform with proprietary databases, package and flight-tracking software, weather, traffic, as well as dynamic dashboards with real-time visibility into shipment transit and last-mile events that are managed by a service center we provide our clients an end-to-end vertical approach for their most critical service delivery needs. Using our proprietary IT platform, we provide real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries.
Authentication: This segment specializes in anti-counterfeit and brand protection.
We do not allocate the following items to the segments: general & administrative expenses and other income (expense).
The following table sets forth the revenue and operating results attributable to each reportable segment and includes a reconciliation of segment revenue to consolidated revenue and operating results to consolidated loss before income tax expense (in thousands):
| Schedule of segment reporting information | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended | ||||||
| March 31, · March 31, | ||||||
| 2025 | 2024 | |||||
| Precision Logistics | Authentication | Consolidated | Precision Logistics | Authentication | Consolidated | |
| NET REVENUE | $4,429 | $26 | $4,455 | $5,614 | $145 | $5,759 |
| COST OF REVENUE | 2,959 | 6 | 2,965 | 3,486 | 13 | 3,499 |
| GROSS PROFIT | 1,470 | 20 | 1,490 | 2,128 | 132 | 2,260 |
| OPERATING EXPENSES | ||||||
| Management and technology | 596 | 28 | 624 | 776 | 256 | 1,032 |
| Research and development | - | 5 | 5 | - | 55 | 55 |
| Sales and marketing | 268 | 2 | 270 | 183 | 127 | 310 |
| Other Segment Items | 428 | (100) | 328 | 339 | 50 | 389 |
| Total Segment expenses | 1,292 | (65) | 1,227 | 1,298 | 488 | 1,786 |
| Segment Income | $178 | $85 | $263 | $830 | $(356) | $474 |
| General and Administrative | (856) | (1,121) | ||||
| Other Income (Expense) | 22 | 94 | ||||
| NET LOSS | $(571) | $(553) | ||||
NOTE 12 –SUBSEQUENT EVENTS
On April 1, 2025, the Company issued 5,792 shares of common stock upon vesting of 7,000 restricted stock units, net of 1,208 shares withheld for taxes related to a stock grant on September 1, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.